B A S E C A R E

Latest Events

Welcome to participate in our activities

As an expert in reproductive health, we would like to welcome you to join us to promote and popularize PGT technology. Together we can participate in important academic activities in reproductive health both home and abroad.

Basecare Medical Announces 2021 Interim Results | The preliminary results of commercialization have been achieved, the sales of PGT-A kits climbs 168%

[Hong Kong, 30 August 2021] Suzhou Basecare Medical Corporation Limited (“Basecare Medical” or the “Company”, together with its subsidiaries, the “Group”, stock code: 2170), an innovative platform of genetic testing kit solutions for assisted reproduction in China, announced its interim results for the six months ended 30 June 2021 (the “Period”).

Three-Child Policy into Law——A Powerful Impetus to Assisted Reproduction Industry

Draft amendment to Law on Population and Family Planning was submitted to the 30th Session of the Standing Committee of the 13th National People’s Congress for deliberation on August 17.

Basecare Awarded the 2021 Science and Technology Innovation Policy Funding of Suzhou Biomedical Industry

Recently, the first batch of municipal funds of the policy support for science and technology innovation in Suzhou biomedical industry in 2021 was realized. Suzhou Basecare Medical Corporation Limited (hereafter “Basecare”) obtained the top-level subsidy of 3 million yuan by the innovative R&D result of the first PGS kit approved for the registration certificate of Class III medical devices in China.

Center for Clinical Transformation Research of Human Sperm Bank by Obstetrics & Gynecology Hospital of Fudan University and Basecare Establishing Officially

Opening ceremony of “Center for Clinical Transformation Research of Human Sperm Bank of Fudan University” was held in Shanghai on the morning of August 13.

Basecare Ranked Among the TOP10 of Assisted Reproduction Enterprises According to “2021 Forbes China Maternity and Childhood Industry List”.

Basecare is ranked among the TOP10 of assisted reproduction enterprises according to “2021 Forbes China Maternity and Childhood Industry List”.

The 4th “Shanghai-Wuhan (Tongji) Reproductive Medicine Forum” Successfully Held with Basecare Participating in the Promotion of Multi-center Study on “Application of AI in Sperm Testing”

The 4th “Shanghai-Wuhan (Tongji) Reproductive Medicine Forum” was successfully held in Shanghai on 17 July 2021. The forum was hosted by three hospitals: Shanghai First Maternity and Infant Hospital, Huashan Hospital affiliated to Fudan University and Tongji Hospital (affiliated to Tongji Medical College of HUST, hereafter TJH). Many authoritative scholars and colleagues in the field of reproduction attended this forum from USA, France, Mainland China and Hong Kong.

Realizing the Dream of “Healthy Fertility” for 1000 Families to Make Love Not Rare——China’s First Large-scale Public Welfare Project of Healthy Fertility for Families with Rare Diseases Initiated by CAIBOCD

In the backdrop of facilitating the implementation of Healthy China strategy, Suzhou China advocates scientific improvement of fertility and enhances the attention and support to prevent rare diseases. On July 15, 2021, adhering to the original intention of passing love and care, CAIBOCD joined with Suzhou Basecare to launch a public welfare campaign called “Realizing the Dream of Healthy Fertility for 1000 Families with Rare Diseases”. It is also the first project targeted to help couples with

Basecare Listed on the “China’s Potential Unicorn Companies”, Seeing Great Opportunities for the Development of Reproductive Health

“2021 China’s Potential Unicorn Companies Report Conference and Suzhou Cooperation and Exchange Conference” held by Suzhou Industrial Park Administrative Committee (SIP) and Greatwall Strategy Consultants (GEI) under the guidance of Suzhou municipal government was launched on June 29, 2021 in the industrial park.